Clinical trial
Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in…
NCT00433420 · IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy, Other · Active, not recruiting
Key facts
| NCT number | NCT00433420 |
|---|---|
| Title | Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer |
| Official title | A Phase III Randomized Study of EC Followed by Paclitaxel Versus FEC Followed by Paclitaxel, All Given Either Every 3 Weeks or 2 Weeks Supported by Pegfilgrastim, for Node Positive Breast Cancer Patients |
| Lead sponsor | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy, Other |
| Collaborators | Gruppo Italiano Mammella (GIM) |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | pegfilgrastim, cyclophosphamide, epirubicin hydrochloride, fluorouracil, paclitaxel, adjuvant therapy |
| Enrollment | 2,000 |
| Start date | Apr 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | Dec 1, 2025 |
| First posted | Feb 12, 2007 |
| Last update posted | May 8, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: